Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ghada, Ayeldeen"'
Autor:
Mahmoud A. Senousy, Olfat G. Shaker, Ahmed H.Z. Elmaasrawy, Ahmed M. Ashour, Shuruq E. Alsufyani, Hany H. Arab, Ghada Ayeldeen
Publikováno v:
Non-coding RNA Research, Vol 9, Iss 4, Pp 995-1008 (2024)
To date, the epigenetic signature of preeclampsia (PE) is not completely deciphered. Oxidative stress-responsive long non-coding RNAs (lncRNAs) are deregulated in preeclamptic placenta; however, their circulating profiles and diagnostic abilities are
Externí odkaz:
https://doaj.org/article/d478cbd0aea04ed886161cb9163598af
Publikováno v:
Türk Patoloji Dergisi, Vol 40, Iss 3, Pp 149-161 (2024)
Objective: A few studies indicate that human papillomavirus (HPV) induces aberrant expression of microRNAs (miRNAs) and correlate this with p16INK4a in oral dysplasia (OD) and oral squamous cell carcinoma (OSCC). Therefore, this study aimed to evalua
Externí odkaz:
https://doaj.org/article/531eca4e274c48f0bc73133163311365
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract The identification of novel screening tools is imperative to empower the early detection of colorectal cancer (CRC). The influence of the long non-coding RNA maternally expressed gene 3 (MEG3) rs941576 single nucleotide polymorphism on CRC s
Externí odkaz:
https://doaj.org/article/930461dd4aad4b1597df56b3bb5b61f2
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: Breast cancer (BC) patients have a higher chance of survival if it is diagnosed at an early stage, which is essential for efficient treatment of the condition. The results of an elevated risk of cancer, including BC, previously associated
Externí odkaz:
https://doaj.org/article/18658bbfe8714b94ba079c49df9835a9
Publikováno v:
Non-coding RNA Research, Vol 8, Iss 2, Pp 187-191 (2023)
Numerous malignancies, including colorectal and liver cancers, are ultimately more likely to occur in obese people, and chronic inflammatory conditions have been linked to this association. We are attempting to determine the clinical relevance of the
Externí odkaz:
https://doaj.org/article/b5a30da7099a407abdb02e71cb90cd84
Publikováno v:
Cancer Nanotechnology, Vol 14, Iss 1, Pp 1-23 (2023)
Abstract Background Colorectal malignant cells (CRC) are one of the world’s main causes of cancer mortality and morbidity. Notwithstanding the plenty of anti-CRC therapeutics, its prognosis remains not selective owing to cancer resistance to these
Externí odkaz:
https://doaj.org/article/344becc6b9f94703a3b7ba714df64442
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Early-stage detection of BC is a critical factor for effective treatment of the disease and can increase the survival rate of BC patients. Long non-coding RNAs can act as miRNA decoys by sequestering miRNAs, thus acting as competing endogenous RNAs a
Externí odkaz:
https://doaj.org/article/b7826d8aedd241f3857a69cb6db66e0f
Autor:
Amr M. Abdelhamid, Ghada Ayeldeen, Olfat G. Shaker, Eman Amer, Mai A. Zaafan, Mohamed R. Herzalla, Mofida A. Keshk
Publikováno v:
Current Medicinal Chemistry. 30
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease (COVID-19), potentially has severe adverse effects, leading to public health crises worldwide. In COVID-19, deficiency of ACE-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea78670a42c08b2aedfc76131d2937d0
https://doi.org/10.2174/0929867330666230515144133
https://doi.org/10.2174/0929867330666230515144133
Publikováno v:
Molecular Biology Reports. 48:6805-6820
Colorectal cancer (CRC) is major aliment around the word, with a cumulative rate of mortality. Metformin (MT) was recently approved as anticancer drug against solid tumors, such as CRC. Resistance to MT therapy remains to be a challenging matter faci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a867d19ede4101e8b3b81ba2a08a353
https://doi.org/10.1007/s11033-021-06680-8
https://doi.org/10.1007/s11033-021-06680-8
Colorectal cancer (CRC) is one of the world's mortality causes. Despite recent breakthroughs in treatment, the prognosis for CRC remains poor due to drug resistance. Raloxifene (RX) was recently licensed for the prevention of CRC. We proposed a uniqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f781da77c8daeb1025f6fe37ee9c7f1
https://doi.org/10.21203/rs.3.rs-1570156/v1
https://doi.org/10.21203/rs.3.rs-1570156/v1
